ArticleJournal of cancer research and clinical oncology2022

Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients.

Sofia Verkhovskaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.